Sign in →

Test Code MEXIL Mexiletine, Serum

Reporting Name

Mexiletine, S

Useful For

Assessing achievement of optimal therapeutic concentrations

 

Assessing potential toxicity

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum Red


Specimen Required


Patient Preparation: Samples should only be collected after patient has been receiving mexiletine for at least 3 days. Trough concentrations should be collected just before administration of the next dose.

Collection Container/Tube: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1.5 mL

Collection Instructions:

1. Samples should only be collected after patient has been receiving mexiletine for at least 3 days.

2. Draw blood immediately before next scheduled dose.

3. Centrifuge within 2 hours of draw and aliquot to remove serum from spun RBCs.


Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Red Refrigerated (preferred) 28 days
  Ambient  28 days
  Frozen  28 days

Reference Values

Trough Value

0.5-2.0 mcg/mL: Therapeutic concentration

>2.0 mcg/mL: Toxic concentration

Day(s) and Time(s) Performed

Monday through Saturday

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

80299

LOINC Code Information

Test ID Test Order Name Order LOINC Value
MEX Mexiletine, S 40779-1

 

Result ID Test Result Name Result LOINC Value
9245 Mexiletine, S 40779-1

Clinical Reference

1. Nader R, Horwath AR, Wittwer CT: In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Sixth edition. St. Louis: Elsevier 2018

2. Burtis CA, Ashwood ER, Bruns DE, et al: In Tietz Textbook of Clinical Chemistry and Molecular Diagnosis. Fifth edition. St Louis: Elsevier. USA 2012

3. Josephson ME, Buxton AE, Marchlinski FE: The tachyarrhythmias: tachycardias. In Harrison's Principles of Internal Medicine. 12th edition. Edited by JD Wilson, E Braunwald, KJ Isselbacher, et al: New York, McGraw-Hill Book Company, 1991, p 915

4. Valdes R Jr, Jortani SA, Gheorghiade M, et al: Standards of Laboratory Practice: Cardiac Drug Monitoring. Clin Chem 1998;44(5):1096-1099

5. Joseph SP, Holt DW: Electrophysiological properties of mexiletine assessed with respect to plasma concentrations. Eur J Cardiol 1980 Feb;11(2):115-121

Method Description

Protein is precipitated from serum and following centrifugation the supernatant is diluted and analyzed by LC-MS/MS.(Unpublished Mayo Method)

Analytic Time

2 days

Reject Due To

Gross hemolysis OK
Gross lipemia Reject
Gross icterus OK
 

Method Name

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Forms

If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.

Secondary ID

9245